The Washington Post is providing this important information about the coronavirus for free. For more free coverage of the coronavirus pandemic, sign up for our Coronavirus Updates newsletter where all stories are free to read.
The remarks from Peter Marks, director of the Center for Biologics Evaluation and Research, came during a webinar as the FDA prepares to meet Oct. 14 and 15 with its outside advisers to discuss boosters for the Moderna and Johnson & Johnson vaccines.
J&J on Tuesday asked the FDA to grant emergency use authorization for a booster dose of its one-shot coronavirus vaccine, making it the third company to ask the Biden administration to approve additional doses.
